NCT07576192 Effects of Deep Transverse Friction Massage and Instrument Assisted Soft Tissue Mobilization in Plantar Fasciitis.
| NCT ID | NCT07576192 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Plantar Fascitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2025-10-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of study is to compare the pain intensity, disability and functional capacity by Deep Transverse Friction Massage and Instrument Assisted Soft Tissue Mobilization Techniques in patients with plantar fasciitis.
Eligibility Criteria
Inclusion Criteria: * Pregnant females Second trimester 12th to 34th week * Multiparous * Plantar fasciitis diagnoses with Windlass test * NPRS pain level 3 to 7 Exclusion Criteria: * History of ankle and foot fractures * Surgery in previous 6 months * Neurologic deficit High risk pregnancy * Previous manual therapy interventions for the foot region * Those who previously received systemic or local steroid injection within 3 months or locally injected with any other material * Dermatological disease i.e; injury, trauma, foot ulcer over the foot
Contact & Investigator
sobia ghafoor, MSPT-OM
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576192 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Plantar Fascitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576192 currently recruiting?
Yes, NCT07576192 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576192 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07576192 clinical trial?
NCT07576192 is sponsored by Riphah International University. The principal investigator is sobia ghafoor, MSPT-OM at Riphah International University. The trial plans to enroll 52 participants.